presented that the prevalence of vitamin D deficiency is lower among adolescents with anorexia nervosa (AN) than among healthy controls in the USA [1] because more girls with AN take vitamin D supplements compared with healthy controls in that country. We measured serum levels of 25-hydroxyvitamin D (25(OH)D) and intact parathyroid hormone (iPTH) in 63 Japanese female patients with AN diagnosed according to DSM-5 (restricting type, n=31; binge eating/purging type, n=32) with an age of 27±8.7(mean±SD)years (range, 18-46) and a body mass index of 14.6±2.5 kg/m 2 (range, 9.9-20.1). Only 9 of the 63 patients with AN (14 %) showed serum 25(OH)D >30 ng/mL, suggesting vitamin D sufficiency. Nine and 45 patients with AN were evaluated as vitamin D insufficiency (30 ng/mL>25(OH)D ≥20 ng/mL) and vitamin D deficiency (25(OH)D <20 ng/mL), respectively. Only two patients were taking multivitamin supplements containing vitamin D2. Twenty of the 63 patients with AN showed increased serum levels of iPTH, indicating secondary hyperparathyroidism. The lack of foods supplemented with vitamin D, recent trends toward avoiding sunbathing, and reductions in the consumption of seafood products are contributing to an increased prevalence of vitamin D insufficiency among the general population in Japan [2] . Surprisingly, the rickets that seemed to be past illness increases again in Japan [3] . The Japanese medical system faces obstacles to vitamin D measurement and treatment because the cost of measuring serum 25(OH)D concentrations as a marker of vitamin D stores is not covered by the national health insurance scheme and therefore must be paid for by the patient. Physicians thus do not regularly measure 25(OH)D, and vitamin D deficiency is often overlooked. Since vitamin D2 tablets are not available to prescribe in Japan, physicians must use 1α-hydroxyvitamin D3 for patients with vitamin D deficiency. In Japan, we have found patients with AN among both sexes at 9-10 years old in elementary schools. The point prevalence of AN among senior high school girls in Tokyo is about 0.26 %. Serum 25(OH)D should be measured in patients with AN, and patients identified as vitamin D deficiency should receive vitamin D medication to prevent osteomalacia or osteoporosis.
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